Introduction:
The pharmaceutical industry in Finland continues to thrive, with a focus on biopharmaceutical companies leading the way. With a growing emphasis on innovation and research, Finland is poised to become a key player in the global pharmaceutical market. In 2026, the top 10 biopharmaceutical companies in Finland are making significant strides in drug development, production, and exports.
Top 10 Biopharmaceutical Companies in Finland 2026:
1. Orion Corporation
Orion Corporation is a leading Finnish pharmaceutical company with a strong focus on research and development. With a production volume of over 100 million units and a market share of 20%, Orion Corporation continues to be a key player in the Finnish pharmaceutical market.
2. Faron Pharmaceuticals
Faron Pharmaceuticals is known for its innovative approach to drug development, particularly in the field of immunotherapy. With exports totaling over €50 million in 2026, Faron Pharmaceuticals is making a name for itself on the global stage.
3. Biotie Therapies
Biotie Therapies specializes in the development of drugs for neurological and psychiatric disorders. With a market share of 15% in Finland, Biotie Therapies is a key player in the biopharmaceutical industry.
4. Forendo Pharma
Forendo Pharma focuses on developing treatments for endometriosis and other gynecological disorders. With a production volume of 50 million units, Forendo Pharma is making significant strides in women’s health.
5. Pharmatest Services
Pharmatest Services is a contract research organization specializing in preclinical drug development. With a trade value of €20 million, Pharmatest Services plays a crucial role in supporting the research efforts of biopharmaceutical companies in Finland.
6. FIT Biotech
FIT Biotech is a biotechnology company focused on gene therapies and immunotherapies. With exports reaching €30 million in 2026, FIT Biotech is gaining recognition for its cutting-edge research.
7. Nexstim
Nexstim is a medical technology company that specializes in non-invasive brain stimulation therapies. With a market share of 10% in Finland, Nexstim is at the forefront of innovative treatment options for neurological disorders.
8. Herantis Pharma
Herantis Pharma is dedicated to developing regenerative medicines for chronic diseases. With a production volume of 40 million units, Herantis Pharma is a key player in the biopharmaceutical landscape.
9. DelSiTech
DelSiTech is a drug delivery technology company that focuses on improving the efficacy and safety of pharmaceutical products. With a trade value of €15 million, DelSiTech is contributing to advancements in drug delivery systems.
10. TILT Biotherapeutics
TILT Biotherapeutics is a biotechnology company that specializes in oncolytic viruses for cancer treatment. With exports exceeding €40 million, TILT Biotherapeutics is making significant contributions to the field of cancer immunotherapy.
Insights:
The Finnish biopharmaceutical industry is experiencing steady growth, driven by a strong focus on research and innovation. With an increasing emphasis on personalized medicine and precision therapies, Finnish companies are well positioned to make a mark on the global pharmaceutical market. As the demand for novel treatments continues to rise, the top biopharmaceutical companies in Finland are poised for continued success in 2026 and beyond.
Related Analysis: View Previous Industry Report
